Latest News and Press Releases

Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and...

Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international...

The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00 per share, to be paid partly in June and November, for the accounting year of 2023. The...

Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma, OSE: VISTN) today announces the financial results for the fourth quarter of 2023. Vistin delivers another strong quarter with...

Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16th of February 2024. Vistin Pharma will host a conference call for all...

The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024. ...

Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024 Record date: 24 January 2024 Payment date: 30 January...

Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for a dividend of NOK 0.75 per share. The dividend is...

 Oslo, Norway, 25th of October 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter of 2023. Vistin delivers another strong quarter with...

Oslo, Norway, 25th of October 2023 The Board of Directors of Vistin Pharma ASA has appointed Magnus Tolleshaug as the new CEO of Vistin Pharma from 1st of January 2024. Magnus Tolleshaug is...